Bannayan-Riley-Ruvalcaba syndrome screening

Jump to: navigation, search

Bannayan-Riley-Ruvalcaba syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Bannayan-Riley-Ruvalcaba Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Bannayan-Riley-Ruvalcaba syndrome screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bannayan-Riley-Ruvalcaba syndrome screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bannayan-Riley-Ruvalcaba syndrome screening

CDC on Bannayan-Riley-Ruvalcaba syndrome screening

Bannayan-Riley-Ruvalcaba syndrome screening in the news

Blogs on Bannayan-Riley-Ruvalcaba syndrome screening

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Bannayan-Riley-Ruvalcaba syndrome screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vamsikrishna Gunnam M.B.B.S[2]

Overview

There is insufficient evidence to recommend routine screening for Bannayan-Riley-Ruvalcaba syndrome (BRRS).

Screening

There is insufficient evidence to recommend routine screening for Bannayan-Riley-Ruvalcaba syndrome (BRRS).

References


Linked-in.jpg